The translational potential of human induced pluripotent stem cells for clinical neurology : The translational potential of hiPSCs in neurology
Abstract
The induced pluripotent state represents a decade-old Nobel prize-winning discovery. Human-induced pluripotent stem cells (hiPSCs) are generated by the nuclear reprogramming of any somatic cell using a variety of established but evolving methods. This approach offers medical science unparalleled experimental opportunity to model an individual patient's disease "in a dish." HiPSCs permit developmentally rationalized directed differentiation into any cell type, which express donor cell mutation(s) at pathophysiological levels and thus hold considerable potential for disease modeling, drug discovery, and potentially cell-based therapies. This review will focus on the translational potential of hiPSCs in clinical neurology and the importance of integrating this approach with complementary model systems to increase the translational yield of preclinical testing for the benefit of patients. This strategy is particularly important given the expected increase in prevalence of neurodegenerative disease, which poses a major burden to global health over the coming decades.
Journal details
Journal Cell Biology and Toxicology
Volume 33
Issue number 2
Pages 129-144
Publication date
Full text links
Publisher website (DOI) 10.1007/s10565-016-9372-7
Europe PubMed Central 27915387
Pubmed 27915387
Keywords
Type of publication